Serum diazepam concentrations in overdose. Their significance

Area of Science:

• Pharmacology
• Clinical Toxicology
• Forensic Science

Background:

• Benzodiazepine overdose is a common clinical presentation.
• Accurate assessment of overdose severity and differentiation from chronic use is crucial for patient management.

Purpose of the Study:

• To correlate total serum benzodiazepine concentrations with clinical manifestations in diazepam overdose.
• To determine serum concentrations of diazepam and its metabolite, nordiazepam, in overdose cases.
• To evaluate the utility of the parent drug to metabolite ratio in differentiating acute overdose from chronic therapy.

Main Methods:

• Serum samples from 93 diazepam overdose cases were analyzed for total benzodiazepine concentrations.
• Diazepam and nordiazepam were quantified in 101 serum specimens using gas chromatography.
• Clinical data, including coma grade and treatment outcomes, were collected and correlated with drug concentrations.

Main Results:

• Total serum benzodiazepine concentrations ranged from 1 to 22 microgram/ml.
• Patients ingesting only diazepam remained awake (grade 0 coma) even with concentrations ten-fold above therapeutic limits.
• The average ratio of diazepam to nordiazepam was 3:1, suggesting its utility in distinguishing acute overdose from chronic use.
• All patients survived with supportive therapy, and those with diazepam-only ingestions did not require hospitalization beyond emergency observation.

Conclusions:

• High serum diazepam concentrations alone do not necessarily correlate with severe clinical manifestations like deep coma.
• The diazepam to nordiazepam ratio can be a valuable indicator for differentiating acute overdose from chronic therapeutic levels.
• Clinical assessment remains paramount; the presence of significant coma (grade I or II) warrants investigation for co-ingestions or alternative causes, irrespective of measured diazepam levels.